EVIDENCE FOR THE IDENTITY OF MURINE GAMMA-INTERFERON AND MACROPHAGE ACTIVATING FACTOR

[1] MOUSE FIBROBLAST (TYPE-I) AND IMMUNE (TYPE-II) INTERFERONS - PRONOUNCED DIFFERENCES IN AFFINITY FOR GANGLIOSIDES AND IN ANTI-VIRAL AND ANTI-GROWTH EFFECTS ON MOUSE LEUKEMIA L-1210R CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05): : 2528 - 2532

[2] BALKWILL FR, 1979, CANCER IMMUNOL IMMUN, V7, P7

[3] PURIFIED HUMAN IMMUNE INTERFERON HAS MORE POTENT ANTICELLULAR ACTIVITY THAN FIBROBLAST OR LEUKOCYTE INTERFERON [J]. CELLULAR IMMUNOLOGY, 1980, 49 (02) : 390 - 394

[4] INTERFERON-INDUCED ENHANCEMENT OF MACROPHAGE-MEDIATED TUMOR CYTOLYSIS AND ITS DIFFERENCE FROM ACTIVATION BY LYMPHOKINES [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (02) : 110 - 114

[5] TYPE-I AND TYPE-II INTERFERONS - DIFFERENTIAL ANTI-VIRAL ACTIONS IN TRANSFORMED-CELLS [J]. JOURNAL OF GENERAL VIROLOGY, 1980, 46 (FEB) : 449 - 454

[6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[7] EVIDENCE THAT TYPE-I AND TYPE-II INTERFERONS HAVE DIFFERENT RECEPTORS [J]. NATURE, 1981, 294 (5843) : 768 - 770

[8] BRANDE IA, 1979, J CHROMATOGR, V172, P207

[9] CRANE JL, 1978, J NATL CANCER I, V61, P871

[10] CROWLE AJ, 1972, ADV TUBERC RES, V18, P31

[1] MOUSE FIBROBLAST (TYPE-I) AND IMMUNE (TYPE-II) INTERFERONS - PRONOUNCED DIFFERENCES IN AFFINITY FOR GANGLIOSIDES AND IN ANTI-VIRAL AND ANTI-GROWTH EFFECTS ON MOUSE LEUKEMIA L-1210R CELLS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05): : 2528 - 2532

[2] BALKWILL FR, 1979, CANCER IMMUNOL IMMUN, V7, P7

[3] PURIFIED HUMAN IMMUNE INTERFERON HAS MORE POTENT ANTICELLULAR ACTIVITY THAN FIBROBLAST OR LEUKOCYTE INTERFERON [J]. CELLULAR IMMUNOLOGY, 1980, 49 (02) : 390 - 394

[4] INTERFERON-INDUCED ENHANCEMENT OF MACROPHAGE-MEDIATED TUMOR CYTOLYSIS AND ITS DIFFERENCE FROM ACTIVATION BY LYMPHOKINES [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (02) : 110 - 114

[5] TYPE-I AND TYPE-II INTERFERONS - DIFFERENTIAL ANTI-VIRAL ACTIONS IN TRANSFORMED-CELLS [J]. JOURNAL OF GENERAL VIROLOGY, 1980, 46 (FEB) : 449 - 454

[6] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[7] EVIDENCE THAT TYPE-I AND TYPE-II INTERFERONS HAVE DIFFERENT RECEPTORS [J]. NATURE, 1981, 294 (5843) : 768 - 770

[8] BRANDE IA, 1979, J CHROMATOGR, V172, P207

[9] CRANE JL, 1978, J NATL CANCER I, V61, P871

[10] CROWLE AJ, 1972, ADV TUBERC RES, V18, P31